Ranchi News Desk

Clinical Trial Supplies Market Worth $2.5 Billion by 2025 | Key Factors Driving Market Growth

 Breaking News
  • No posts were found

Clinical Trial Supplies Market Worth $2.5 Billion by 2025 | Key Factors Driving Market Growth

June 11
20:48 2020
Clinical Trial Supplies Market Worth $2.5 Billion by 2025 | Key Factors Driving Market Growth

The prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US)
Clinical Trial Supplies Market Report Provides Crucial Industry Insights That Will Help Your Business Grow. Know The Key Industry Trends.

According to the new market research report Clinical Trial Supplies Market by Products & Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology, Blood Disorders) – Global Forecast to 2025″, published by MarketsandMarkets™, the Clinical Trial Supplies Market is projected to reach USD 2.5 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 7.8%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

The increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations are the key factors driving the growth of this market. 

clinical-trial-supplies-market1

Logistics services segment to dominate the Clinical Trial Supplies Market in 2020

Based on service, the market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of this market in 2020, primarily due to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.

Browse in-depth TOC on “Clinical Trial Supplies Market

132 – Tables
37 – Figures  
158 – Pages

Phase III segment to register the highest growth in the market, by phase

Based on phase, the market is segmented into phase I, phase II, phase III, phase IV, and BA/BE studies. The phase III segment is expected to account for the largest share of the market in 2020. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the fact that phase III trials are the most expensive, time-consuming, and difficult to design and run.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059

North America is the largest regional market for clinical trial supplies

The Global Clinical Trial Supplies Market is segmented into North AmericaEurope, the Asia Pacific, and the Rest of the World. North America is the largest regional market for clinical trial supplies, followed by Europe. The large share of the North American market can primarily be attributed to the presence of well-established CROs and the high and growing R&D expenditure by pharmaceutical and biopharmaceutical companies in the region.

The prominent players operating in the global Clinical Trial Supplies Market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US).

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html